P G Moorman1, H Kuwabara, R C Millikan, B Newman. 1. Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn., USA. patricia.moorman@yale.edu
Abstract
OBJECTIVES: This study examined the association between menopausal hormones and breast cancer in a biracial population. METHODS: Logistic regression was used to calculate odds ratios for breast cancer associated with hormone use among 397 cases and 425 controls, all menopausal women. RESULTS: Odds ratios for ever use of hormones were 0.8 (95% confidence interval [CI] = 0.5, 1.2) for White women and 0.7 (95% CI = 0.4, 1.2) for Black women. Risk was not increased with longer duration of use or more recent use. CONCLUSIONS: Breast cancer risk was not increased among White or Black women who used menopausal hormones, despite patterns of use varying considerably between races.
OBJECTIVES: This study examined the association between menopausal hormones and breast cancer in a biracial population. METHODS: Logistic regression was used to calculate odds ratios for breast cancer associated with hormone use among 397 cases and 425 controls, all menopausal women. RESULTS: Odds ratios for ever use of hormones were 0.8 (95% confidence interval [CI] = 0.5, 1.2) for White women and 0.7 (95% CI = 0.4, 1.2) for Black women. Risk was not increased with longer duration of use or more recent use. CONCLUSIONS:Breast cancer risk was not increased among White or Black women who used menopausal hormones, despite patterns of use varying considerably between races.
Authors: M Sillero-Arenas; M Delgado-Rodriguez; R Rodigues-Canteras; A Bueno-Cavanillas; R Galvez-Vargas Journal: Obstet Gynecol Date: 1992-02 Impact factor: 7.661
Authors: G A Colditz; S E Hankinson; D J Hunter; W C Willett; J E Manson; M J Stampfer; C Hennekens; B Rosner; F E Speizer Journal: N Engl J Med Date: 1995-06-15 Impact factor: 91.245
Authors: Nathan L DeBono; Whitney R Robinson; Jennifer L Lund; Chiu Kit Tse; Patricia G Moorman; Andrew F Olshan; Melissa A Troester Journal: J Womens Health (Larchmt) Date: 2017-06-01 Impact factor: 2.681
Authors: Robert C Millikan; Beth Newman; Chiu-Kit Tse; Patricia G Moorman; Kathleen Conway; Lynn G Dressler; Lisa V Smith; Miriam H Labbok; Joseph Geradts; Jeannette T Bensen; Susan Jackson; Sarah Nyante; Chad Livasy; Lisa Carey; H Shelton Earp; Charles M Perou Journal: Breast Cancer Res Treat Date: 2007-06-20 Impact factor: 4.872
Authors: Lynette S Phillips; Robert C Millikan; Jane C Schroeder; Jill S Barnholtz-Sloan; Beverly J Levine Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-05 Impact factor: 4.254
Authors: Hilda Razzaghi; Melissa A Troester; Gretchen L Gierach; Andrew F Olshan; Bonnie C Yankaskas; Robert C Millikan Journal: Breast Cancer Res Treat Date: 2012-08-03 Impact factor: 4.872
Authors: Kathleen Conway; Eloise Parrish; Sharon N Edmiston; Dawn Tolbert; Chiu-Kit Tse; Patricia Moorman; Beth Newman; Robert C Millikan Journal: Breast Cancer Res Date: 2007 Impact factor: 6.466
Authors: Robert C Millikan; Jon Player; Allan René de Cotret; Patricia Moorman; Gary Pittman; Vani Vannappagari; Chiu-Kit J Tse; Temitope Keku Journal: Breast Cancer Res Date: 2004-04-07 Impact factor: 6.466